0.00Open10.35Pre Close0 Volume0 Open Interest71.00Strike Price0.00Turnover162.76%IV5.65%PremiumDec 13, 2024Expiry Date6.00Intrinsic Value100Multiplier0DDays to Expiry4.35Extrinsic Value100Contract SizeAmericanOptions Type0.9832Delta0.0140Gamma12.73Leverage Ratio-0.2833Theta0.0004Rho12.51Eff Leverage0.0008Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet